The language of hope: Therapeutic intent in stem-cell clinical trials

AJOB Primary Research

Volumn 1, Issue 3, 2010, Pages 4-11

  Scott, Christopher Thomas ^a   DeRouen, Mindy C ^a   Crawley, LaVera M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Clinical trials; Electronic registries; Stem cell; Therapeutic misconception

Indexed keywords

EID: 79955857881     PISSN: 21507716     EISSN: 21507724     Source Type: Journal    
DOI: 10.1080/21507716.2010.505899     Document Type: Article

References (32)

1. Antonelli, M., and G. Mercurio. 2009. Reporting, access, and transparency: Better infrastructure of clinical trials. Critical Care Medicine 37(1 suppl.): S178-S183.
2. Appelbaum, P. S., L. H. Roth, and C. Lidz. 1982. The therapeutic misconception: informed consent in psychiatric research. International Journal of Law and Psychiatry 5(3-4): 319-329.
3. Balsam, L. B., A. J. Wagers, J. L. Christensen, et al. 2004. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983): 607-608.
4. Boissel, J. P., and M. C. Haugh. 1997. Clinical trial registries and ethics review boards: The results of a survey by the FICHTRE project. Fundamentals of Clinical Pharmacology 11(3): 281-284.
5. Crawley, L. M., L. D. Hisaw, and J. Illes. 2009. Direct-to-consumer advertising in black and white: Racial differences in placement patterns of print advertisements for health products andmessages. Health Marketing Quarterly 26(4): 1-14.
6. Daugherty, C. K., D. M. Banik, L. Janish, and M. J. Ratain. 2000. Quantitative analysis of ethical issues in phase I trials: A survey interview of 144 advanced cancer patients. IRB 22(3): 6-14.
7. Flesch, R. 1948. A new readability yardstick. Journal of Applied Psychology 32: 221-233.
8. Food and Drug Administration. 1997. Section 113, Information program on clinical trials for serious or life-threatening diseases. Food and Drug Administration Modernization Act of 1997. Public Law 105-115.
9. Greenacre, M. J. 1984. Theory and applications of correspondence analysis. London: Academic Press.
10. Greenacre, M. 1992. Correspondence analysis in medical research. Statistical Methods in Medical Research 1992(1): 97-117.
11. Greenacre, M. J. 2007. Correspondence analysis in practice, 2nd ed. London: Chapman &Hall/CRC.
12. Greenacre, M. J., and J. R. Blasius, eds. 2006. Multiple correspondence analysis and related methods. Boca Raton, FL: Chapman&Hall/CRC.
13. Hanson, E., M. Lindsay, and K. Chien. 2009. Regeneration next: Towards heart stem cell therapeutics. Cell Stem Cell 5(4): 364-377.
14. Henderson, G. E., M.M. Easter, C. Zimmer, et al. 2006. Therapeutic misconception in early phase gene transfer trials. Social Science and Medicine 62(1): 239-253.
15. Horton, R. 2006. Trial registers: Protecting patients, advancing trust. Lancet 367(9523): 1633-1635.
16. Kimmelman, J., and A. Levenstadt. 2005. Elements of style: Consent form language and the therapeutic misconception in phase 1 gene transfer trials. Human Gene Therapy 16(4): 502-508.
17. King, N. M., G. E. Henderson, L. R. Churchill, et al. 2005. Consent forms and the therapeutic misconception: The example of gene transfer research. IRB 27(1): 1-8.
18. McCray, A. T. 2000. Better access to information about clinical trials. Annals of Internal Medicine 133: 609-614.
19. Meinert, C. L. 1988. Toward prospective registration of clinical trials. Controlled Clinical Trials 9(1): 1-5.
20. Miller, M. 2000. Phase I cancer trials. Acollusion of misunderstanding. Hastings Center Report 30(4): 34-43.
21. Moreno, J. 2003. Abandon all hope? The therapeutic misconception and informed consent. Cancer Investigation 21(3): 481-482.
22. Notice of public process for the expansion of Clinical Trials. gov registry. Federal Register 73(99): 29525-29526.
23. Neuendorf, K. A. 2002. The content analysis guidebook. Thousand Oaks, CA: Sage.
24. Paasche-Orlow, M. K., H. A. Taylor, and F. L. Brancati. 2003. Readability standards for informed-consent forms as compared with actual readability. New England Journal of Medicine 348(8): 721-726.
25. Raja, U., T. Mitchell, T. Day, and J. M. Hardin. 2008. Text mining in healthcare. Applications and opportunities. Journal of Healthcare Information Management 22(3): 52-56.
26. Roberts, A., R. Gaizauskas, M. Hepple, and Y. Guo. 2008. Mining clinical relationships from patient narratives. BMC Bioinformatics 9(suppl. 11): S3.
27. Rosenzweig, A. 2006. Mixed results from mixed cells. New England Journal of Medicine 355(12): 1274-1277.
28. Sheikh, A., F. Cao, J.M. Spin, et al. 2007. Genomic profiling of bone marrow cells transplanted into the heart. Circulation 116: II-167.
29. Sim, I., A.-W. Chan, A.M. Gülmezoglu, T. Evans, and T. Pang. 2006. Clinical trial registration: transparency is the watchword. Lancet 367: 1631-1633.
30. Simes, R. J. 1986. Publication bias: The case for an international registry of clinical trials. Journal ofClinical Oncology 4(10): 1529-1541.
31. Wollert, K., G. Meyer, J. Lotz, et al. 2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364(9429): 141-148.
32. Zarin, D. A., N. C. Ide, T. Tse, et al. 2007. Issues in the registration of clinical trials. Journal of the American Medical Association 297(19): 2112-2120.